Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5‐methyl‐tetrahydrofolate and 5‐formyl‐tetrahydrofolate
Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one‐carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the bioc...
Saved in:
Published in | Journal of cellular physiology Vol. 234; no. 9; pp. 15010 - 15024 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.09.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-9541 1097-4652 1097-4652 |
DOI | 10.1002/jcp.28140 |
Cover
Loading…
Abstract | Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one‐carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one‐carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one‐carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5‐formyl‐THF and 5‐methyl‐THF on the MTX toxicity almost as normal cell lines.
Alteration of one‐carbon metabolism might be a metabolic cause of intellectual disability in Down syndrome. Folate cycle is a one‐carbon group transfer pathway. The rescue effect on methotrexate (MTX) toxicity mediated by folates: folic acid, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, when administered with MTX. |
---|---|
AbstractList | Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one‐carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one‐carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one‐carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5‐formyl‐THF and 5‐methyl‐THF on the MTX toxicity almost as normal cell lines. Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one-carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one-carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one-carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5-formyl-THF, and 5-methyl-THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5-formyl-THF, 5-methyl-THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5-formyl-THF and 5-methyl-THF on the MTX toxicity almost as normal cell lines.Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one-carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one-carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one-carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5-formyl-THF, and 5-methyl-THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5-formyl-THF, 5-methyl-THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5-formyl-THF and 5-methyl-THF on the MTX toxicity almost as normal cell lines. Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of one‐carbon metabolism was described as the possible metabolic cause of the intellectual disability development in subjects with DS. One of the biochemical pathways involved in the one‐carbon group transfer is the folate cycle. The cytotoxic drug methotrexate (MTX) is a folic acid (FA) analogue which inhibits the activity of dihydrofolate reductase enzyme involved in the one‐carbon metabolic cycle. Trisomy 21 cells are more sensitive to the MTX effect than euploid cells, and in 1986 Jérôme Lejeune and Coll. demonstrated that MTX was twice as toxic in trisomy 21 lymphocytes than in control cells. In the present work, the rescue effect on MTX toxicity mediated by FA and some of its derivatives, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells, was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, administered together with MTX. In conclusion, trisomy 21 fibroblast cell lines showed a good response to the rescue effects of 5‐formyl‐THF and 5‐methyl‐THF on the MTX toxicity almost as normal cell lines. Alteration of one‐carbon metabolism might be a metabolic cause of intellectual disability in Down syndrome. Folate cycle is a one‐carbon group transfer pathway. The rescue effect on methotrexate (MTX) toxicity mediated by folates: folic acid, tetrahydrofolate (THF), 5‐formyl‐THF, and 5‐methyl‐THF, in both normal and trisomy 21 skin fibroblast cells was evaluated. A statistically significant rescue effect was obtained by 5‐formyl‐THF, 5‐methyl‐THF, and their combination, when administered with MTX. |
Author | Vitale, Lorenza Cicchini, Elena Piovesan, Allison Caracausi, Maria Lauriola, Mattia Antonaros, Francesca Serpieri, Valentina Strippoli, Pierluigi Cocchi, Guido Locatelli, Chiara |
Author_xml | – sequence: 1 givenname: Lorenza surname: Vitale fullname: Vitale, Lorenza organization: University of Bologna – sequence: 2 givenname: Valentina surname: Serpieri fullname: Serpieri, Valentina organization: University of Pavia – sequence: 3 givenname: Mattia surname: Lauriola fullname: Lauriola, Mattia organization: University of Bologna – sequence: 4 givenname: Allison surname: Piovesan fullname: Piovesan, Allison organization: University of Bologna – sequence: 5 givenname: Francesca surname: Antonaros fullname: Antonaros, Francesca organization: University of Bologna – sequence: 6 givenname: Elena surname: Cicchini fullname: Cicchini, Elena organization: University of Bologna – sequence: 7 givenname: Chiara surname: Locatelli fullname: Locatelli, Chiara organization: St. Orsola‐Malpighi Polyclinic – sequence: 8 givenname: Guido surname: Cocchi fullname: Cocchi, Guido organization: University of Bologna – sequence: 9 givenname: Pierluigi orcidid: 0000-0001-8769-8832 surname: Strippoli fullname: Strippoli, Pierluigi email: pierluigi.strippoli@unibo.it organization: University of Bologna – sequence: 10 givenname: Maria surname: Caracausi fullname: Caracausi, Maria organization: University of Bologna |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30667057$$D View this record in MEDLINE/PubMed |
BookMark | eNp90ctu1DAUBmALFdFpYcELIEtsYJHW11yWaEQpqBIsYB2dOMcaj5J4sB212fUREI_YJ8HTKSwqYGVL_v4j6_wn5GjyExLykrMzzpg435rdmai5Yk_IirOmKlSpxRFZ5TdeNFrxY3IS45Yx1jRSPiPHkpVlxXS1Ij8v5xEmmoKLflyo4NS6LvhugJgiDRjNjHTEtPEp4A0kpMnfOEPRWjSJgk0YchohjTgleu3Shuq72x_7yDLkS8IUYLP0wVs_7PMw9ffC-jD-VTwnTy0MEV88nKfk28X7r-vL4urzh4_rd1eFkVqywgCvLLd1L0Bi19SAJfSihrIEbWoryo4rgUKzsgfeN0op0Wtdy0b3gJ0U8pS8OczdBf99xpja0UWDwwAT-jm2gleN4nlNdaavH9Gtn8OUf9cKIZpa1VrwrF49qLkbsW93wY0Qlvb3tjN4ewAm-BgD2j-Es3bfZJubbO-bzPb8kTUuQXJ-yttyw_8S127A5d-j20_rL4fELwhutYQ |
CitedBy_id | crossref_primary_10_3390_ijerph19052955 crossref_primary_10_2174_1874467212666191023120118 crossref_primary_10_1002_biof_2044 crossref_primary_10_1186_s40246_021_00325_4 crossref_primary_10_3389_fmed_2022_1006891 crossref_primary_10_1016_j_jpeds_2020_01_032 crossref_primary_10_1038_s41598_021_83379_7 |
Cites_doi | 10.1006/cbir.2002.0861 10.1016/0006-291X(85)91641-9 10.1016/j.ygeno.2017.06.004 10.1203/00006450-198002000-00003 10.1007/978-3-7091-6721-2_4 10.3324/haematol.2016.142794 10.12659/MSM.899021 10.1111/j.1601-5223.1986.tb00654.x 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.0.CO;2-7 10.1002/jcp.1040830112 10.1093/hmg/6.12.2043 10.1016/j.stem.2012.08.004 10.1136/bmj.39465.544028.AE 10.1016/0024-3205(79)90276-5 10.1007/s00726-002-0337-1 10.1177/1947601911405841 10.7554/eLife.16220.036 10.3109/00498254.2013.845705 10.1093/database/baw153 10.1111/j.1365-2141.1995.tb08390.x 10.1007/BF00685122 10.1080/00365521.2017.1407440 10.4161/rna.23770 10.1080/01443615.2016.1250730 10.1007/s12032-011-0075-x 10.1002/pbc.20092 10.1016/j.freeradbiomed.2005.03.023 10.1371/journal.pone.0008394 10.1182/blood-2013-07-453480 10.1007/BF00444952 10.1002/jcp.25471 10.1186/1471-2350-7-24 10.1016/0014-4827(65)90219-3 10.1523/JNEUROSCI.3728-10.2010 10.1038/s41598-017-18456-x 10.14340/spp.2013.12R0005 10.1007/978-3-319-98788-0_10 10.1016/S0140-6736(86)92704-2 10.1172/JCI90253 10.1089/scd.2015.0061 10.1038/s41598-018-20834-y 10.3892/or.2016.5264 10.1080/10428190701824569 10.3389/fgene.2018.00125 |
ContentType | Journal Article |
Copyright | 2019 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2019 Wiley Periodicals, Inc. |
DBID | AAYXX CITATION NPM 7TK 7U7 8FD C1K FR3 K9. P64 RC3 7X8 |
DOI | 10.1002/jcp.28140 |
DatabaseName | CrossRef PubMed Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Genetics Abstracts Technology Research Database Toxicology Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Genetics Abstracts PubMed MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Biology |
EISSN | 1097-4652 |
EndPage | 15024 |
ExternalDocumentID | 30667057 10_1002_jcp_28140 JCP28140 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Fondazione Umano Progresso funderid: 5421/2017‐III/13.13 – fundername: Fondazione Umano Progresso grantid: 5421/2017-III/13.13 |
GroupedDBID | --- -DZ -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 36B 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 9M8 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDPE ABEFU ABEML ABIJN ABJNI ABPPZ ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACNCT ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BQCPF BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMB EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ H~9 IH2 IX1 J0M JPC KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M56 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MVM MXFUL MXSTM N04 N05 N9A NEJ NF~ NNB O66 O9- OHT OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RWR RX1 RYL S10 SAMSI SUPJJ SV3 TN5 TWZ UB1 UPT V2E V8K VQP W8V W99 WBKPD WH7 WIB WIH WIK WJL WNSPC WOHZO WQJ WRC WXSBR WYB WYISQ X7M XG1 XJT XOL XPP XSW XV2 Y6R YQT YZZ ZGI ZXP ZZTAW ~IA ~WT AAYXX ADXHL AETEA AEYWJ AGHNM AGQPQ AGYGG CITATION NPM PKN 7TK 7U7 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY C1K FR3 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3530-ca17f1f8d2a3eb98ae6ad28a66a5c8f26b142e2506da1d94442d558395daeb323 |
IEDL.DBID | DR2 |
ISSN | 0021-9541 1097-4652 |
IngestDate | Fri Jul 11 02:56:43 EDT 2025 Mon Jul 21 01:54:19 EDT 2025 Wed Feb 19 02:25:44 EST 2025 Thu Apr 24 22:54:46 EDT 2025 Tue Jul 01 01:32:00 EDT 2025 Wed Jan 22 16:38:31 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | folates methotrexate fibroblasts trisomy 21 one-carbon metabolism |
Language | English |
License | 2019 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3530-ca17f1f8d2a3eb98ae6ad28a66a5c8f26b142e2506da1d94442d558395daeb323 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-8769-8832 |
PMID | 30667057 |
PQID | 2229848521 |
PQPubID | 1006363 |
PageCount | 15 |
ParticipantIDs | proquest_miscellaneous_2179417058 proquest_journals_2229848521 pubmed_primary_30667057 crossref_primary_10_1002_jcp_28140 crossref_citationtrail_10_1002_jcp_28140 wiley_primary_10_1002_jcp_28140_JCP28140 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2019 2019-09-00 2019-Sep 20190901 |
PublicationDateYYYYMMDD | 2019-09-01 |
PublicationDate_xml | – month: 09 year: 2019 text: September 2019 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Journal of cellular physiology |
PublicationTitleAlternate | J Cell Physiol |
PublicationYear | 2019 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | e_1_2_8_1_11_1 Lejeune J. (e_1_2_8_1_23_1) 1979; 22 e_1_2_8_1_36_1 e_1_2_8_1_57_1 e_1_2_8_1_34_1 e_1_2_8_1_55_1 e_1_2_8_1_53_1 e_1_2_8_1_30_1 e_1_2_8_1_51_1 e_1_2_8_1_9_1 Lejeune J. (e_1_2_8_1_24_1) 1959; 248 Lejeune J. (e_1_2_8_1_26_1) 1986; 29 Bottiglieri T. (e_1_2_8_1_3_1) 2010 e_1_2_8_1_27_1 e_1_2_8_1_29_1 e_1_2_8_1_48_1 e_1_2_8_1_22_1 e_1_2_8_1_47_1 e_1_2_8_1_45_1 e_1_2_8_1_43_1 e_1_2_8_1_20_1 e_1_2_8_1_41_1 Feaster W. W. (e_1_2_8_1_13_1) 1977; 29 Urakami K. (e_1_2_8_1_54_1) 1996; 7 e_1_2_8_1_7_1 e_1_2_8_1_5_1 Noguchi K. (e_1_2_8_1_33_1) 2018; 16 e_1_2_8_1_19_1 Pelleri M. C. (e_1_2_8_1_39_1) 2016; 25 e_1_2_8_1_15_1 e_1_2_8_1_17_1 e_1_2_8_1_38_1 e_1_2_8_1_12_1 e_1_2_8_1_35_1 e_1_2_8_1_58_1 e_1_2_8_1_14_1 e_1_2_8_1_56_1 e_1_2_8_1_31_1 e_1_2_8_1_10_1 e_1_2_8_1_52_1 e_1_2_8_1_8_1 Shane B. (e_1_2_8_1_46_1) 2010 e_1_2_8_1_28_1 Stover P. J. (e_1_2_8_1_50_1) 2010 e_1_2_8_1_25_1 e_1_2_8_1_44_1 e_1_2_8_1_21_1 e_1_2_8_1_40_1 Rosenblatt D. S. (e_1_2_8_1_42_1) 1982; 21 e_1_2_8_1_2_1 e_1_2_8_1_6_1 Steiner M. E. (e_1_2_8_1_49_1) 1982; 95 e_1_2_8_1_4_1 e_1_2_8_1_16_1 Necchi D. (e_1_2_8_1_32_1) 2015; 780 e_1_2_8_1_18_1 e_1_2_8_1_37_1 |
References_xml | – volume: 7 start-page: 82 issue: 2 year: 1996 ident: e_1_2_8_1_54_1 article-title: Analysis of amyloid precursor protein mRNAs in skin fibroblasts in Down’s syndrome publication-title: Dementia – ident: e_1_2_8_1_58_1 doi: 10.1006/cbir.2002.0861 – ident: e_1_2_8_1_7_1 doi: 10.1016/0006-291X(85)91641-9 – ident: e_1_2_8_1_40_1 doi: 10.1016/j.ygeno.2017.06.004 – ident: e_1_2_8_1_57_1 doi: 10.1203/00006450-198002000-00003 – ident: e_1_2_8_1_43_1 doi: 10.1007/978-3-7091-6721-2_4 – ident: e_1_2_8_1_55_1 doi: 10.3324/haematol.2016.142794 – ident: e_1_2_8_1_16_1 doi: 10.12659/MSM.899021 – ident: e_1_2_8_1_18_1 doi: 10.1111/j.1601-5223.1986.tb00654.x – ident: e_1_2_8_1_31_1 doi: 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.0.CO;2-7 – volume: 16 start-page: 1827 issue: 2 year: 2018 ident: e_1_2_8_1_33_1 article-title: The mitochondrial one‐carbon metabolic pathway is associated with patient survival in pancreatic cancer publication-title: Oncology Letters – volume: 29 start-page: 563 issue: 6 year: 1977 ident: e_1_2_8_1_13_1 article-title: Dosage effects for superoxide dismutase‐1 in nucleated cells aneuploid for chromosome 21 publication-title: American Journal of Human Genetics – ident: e_1_2_8_1_45_1 doi: 10.1002/jcp.1040830112 – ident: e_1_2_8_1_4_1 doi: 10.1093/hmg/6.12.2043 – start-page: pp. 355 volume-title: Folate in health and disease year: 2010 ident: e_1_2_8_1_3_1 – ident: e_1_2_8_1_28_1 doi: 10.1016/j.stem.2012.08.004 – volume: 21 start-page: 718 issue: 3 year: 1982 ident: e_1_2_8_1_42_1 article-title: Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate‐treated human cells in relation to the accumulation of methotrexate polyglutamates publication-title: Molecular Pharmacology – volume: 95 start-page: 515 issue: 2 year: 1982 ident: e_1_2_8_1_49_1 article-title: Normal formation and repair of gamma‐radiation‐induced single and double strand DNA breaks in Down syndrome fibroblasts publication-title: Mutation Research/DNA Repair – ident: e_1_2_8_1_12_1 doi: 10.1136/bmj.39465.544028.AE – ident: e_1_2_8_1_47_1 doi: 10.1016/0024-3205(79)90276-5 – ident: e_1_2_8_1_9_1 doi: 10.1007/s00726-002-0337-1 – ident: e_1_2_8_1_34_1 doi: 10.1177/1947601911405841 – volume: 22 start-page: 67 issue: 2 year: 1979 ident: e_1_2_8_1_23_1 article-title: Biochemical investigations and trisomy 21 (author’s transl) publication-title: Annales de génétique – volume: 248 start-page: 602 issue: 4 year: 1959 ident: e_1_2_8_1_24_1 article-title: Human chromosomes in tissue cultures publication-title: Comptes Rendus Hebdomadaires des Seances de l’Academie des Sciences – volume: 25 start-page: 2525 year: 2016 ident: e_1_2_8_1_39_1 article-title: Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on 21q22.13 as critical to the phenotype publication-title: Human Molecular Genetics – ident: e_1_2_8_1_52_1 doi: 10.7554/eLife.16220.036 – ident: e_1_2_8_1_44_1 doi: 10.3109/00498254.2013.845705 – ident: e_1_2_8_1_41_1 doi: 10.1093/database/baw153 – ident: e_1_2_8_1_37_1 doi: 10.1111/j.1365-2141.1995.tb08390.x – ident: e_1_2_8_1_25_1 doi: 10.1007/BF00685122 – ident: e_1_2_8_1_56_1 doi: 10.1080/00365521.2017.1407440 – ident: e_1_2_8_1_11_1 doi: 10.4161/rna.23770 – ident: e_1_2_8_1_29_1 doi: 10.1080/01443615.2016.1250730 – ident: e_1_2_8_1_8_1 doi: 10.1007/s12032-011-0075-x – ident: e_1_2_8_1_53_1 doi: 10.1002/pbc.20092 – ident: e_1_2_8_1_19_1 doi: 10.1016/j.freeradbiomed.2005.03.023 – ident: e_1_2_8_1_2_1 doi: 10.1371/journal.pone.0008394 – ident: e_1_2_8_1_17_1 doi: 10.1182/blood-2013-07-453480 – volume: 29 start-page: 16 issue: 1 year: 1986 ident: e_1_2_8_1_26_1 article-title: Metabolism of monocarbons and trisomy 21: Sensitivity to methotrexate publication-title: Annales de génétique – ident: e_1_2_8_1_35_1 doi: 10.1007/BF00444952 – ident: e_1_2_8_1_6_1 doi: 10.1002/jcp.25471 – ident: e_1_2_8_1_27_1 doi: 10.1186/1471-2350-7-24 – ident: e_1_2_8_1_10_1 doi: 10.1016/0014-4827(65)90219-3 – start-page: pp. 49 volume-title: Folate in Health and Disease year: 2010 ident: e_1_2_8_1_50_1 – start-page: pp. 1 volume-title: Folate in health and disease year: 2010 ident: e_1_2_8_1_46_1 – ident: e_1_2_8_1_15_1 doi: 10.1523/JNEUROSCI.3728-10.2010 – ident: e_1_2_8_1_20_1 doi: 10.1038/s41598-017-18456-x – ident: e_1_2_8_1_51_1 doi: 10.14340/spp.2013.12R0005 – ident: e_1_2_8_1_21_1 doi: 10.1007/978-3-319-98788-0_10 – ident: e_1_2_8_1_36_1 doi: 10.1016/S0140-6736(86)92704-2 – volume: 780 start-page: 15 year: 2015 ident: e_1_2_8_1_32_1 article-title: Defective DNA repair and increased chromatin binding of DNA repair factors in Down syndrome fibroblasts publication-title: Mutation Research/DNA Repair – ident: e_1_2_8_1_22_1 doi: 10.1172/JCI90253 – ident: e_1_2_8_1_48_1 doi: 10.1089/scd.2015.0061 – ident: e_1_2_8_1_5_1 doi: 10.1038/s41598-018-20834-y – ident: e_1_2_8_1_30_1 doi: 10.3892/or.2016.5264 – ident: e_1_2_8_1_14_1 doi: 10.1080/10428190701824569 – ident: e_1_2_8_1_38_1 doi: 10.3389/fgene.2018.00125 |
SSID | ssj0009933 |
Score | 2.3377204 |
Snippet | Trisomy 21 causes Down syndrome (DS), the most common human genetic disorder and the leading genetic cause of intellectual disability. The alteration of... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 15010 |
SubjectTerms | Biotechnology Carbon Carbon cycle Cell lines Cytotoxicity Dihydrofolate reductase Down's syndrome Fibroblasts folates Folic acid Genetic disorders Intellectual disabilities Lymphocytes Metabolism Methotrexate one‐carbon metabolism Skin Statistical analysis Tetrahydrofolic acid Toxicity Trisomy trisomy 21 |
Title | Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5‐methyl‐tetrahydrofolate and 5‐formyl‐tetrahydrofolate |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.28140 https://www.ncbi.nlm.nih.gov/pubmed/30667057 https://www.proquest.com/docview/2229848521 https://www.proquest.com/docview/2179417058 |
Volume | 234 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS91AEB5EEHxp66XtabWsRUpfcjSb3Zw9-CRSEcFSSgUfCmGv0NbmiGcPePrUnyD-xP6SzmwuYqtQ-hbIbDbZzMx-M5l8A7AtXU7MWSbzchwyobTJDA8-40bYwsgQXCL1OXlfHp2K4zN5tgB73b8wDT9En3Ajy0j-mgxcm-nOLWnoV3sx5MTXhP6XarUIEH28pY4at23kUwmCFHnHKrTLd_qRd_eivwDmXbyaNpzDx_C5u9WmzuTbcBbN0P74g8XxP5_lCTxqgSjbbzRnBRZ8vQpr-zUG4d_n7A1LpaEp574KS03Hyvka3KSkP4vUuRDFeM4CTjwxiMHjlGHobmeepa7U8dJfIY5lcXL1xbKmbISljuSsL25nlAVm8tfPaxoyP8eD6CO6v7nD7QGDbhyva5ckCFzfK7EOp4fvPh0cZW1bh8wWstjNrM5HIQ_KcV14M1bal9pxpctSS6sCLykv5RGalU7nbiyE4E5KBHLSaQz9efEUFutJ7Z8Dc3IUtERlwzBJ-DDCa3Fj0MmgW1K5DAN4273gyrac59R647xq2Jp5hStfpZUfwOte9KIh-rhPaKPTkqq19WlFHdGVUIiDBrDVn0YrpU8vuvaTGcqQ3yPmIjWAZ4129bMUVGeMsBlvNunIw9NXxwcf0sGLfxd9CcuI8dqyuA1YjJczv4k4KppXyWB-A9KAH38 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bahRBEC1iRPTFS2J0NWorIr7MJtPTPdsLvoRgWGMSRBLIiwx9BTXOhqQXsj75CeIn-iVW9VxCNIL4NrDV27OzVdWnamvPAXguXU7MWSbzchwyobTJDA8-40bYwsgQXCL12d0rJwdi-1AeLsCr7r8wDT9E33CjyEj5mgKcGtJr56yhn-zxkBNh0xW4SoreqaB6f04eNW6F5NMQghR5xyu0ztf6pRdPoz8g5kXEmo6crVvwobvZZtLk83AWzdB-_Y3H8X8_zW242WJRttE4zx1Y8PUSLG_UWId_mbMXLE2Hprb7ElxrRCvny_Aj9f1ZJPFCNOM5C7jz1CAMj6cMq3c78ywJU8cTf4ZQlsXp2UfLmskRlkTJWT_fzqgRzOTPb99pyfwIL6KPmAHnDk8IrLtxva5dsiB8fanFXTjYer2_OclaZYfMFrJYz6zORyEPynFdeDNW2pfacaXLUkurAi-pNeURnZVO524shOBOSsRy0mms_nmxAov1tPb3gTk5Clqiv2GlJHwY4XtxYzDPYGZSuQwDeNl9w5Vtac9JfeOoagibeYVPvkpPfgDPetPjhuvjMqPVzk2qNtxPKxJFV0IhFBrA0_5lDFT69UXXfjpDG0p9RF6kBnCvca9-l4JGjRE5480mJ_n79tX25rt08eDfTZ_A9cn-7k6182bv7UO4gZCvnZJbhcV4MvOPEFZF8zhFzy-bIyOa |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9RAEJ8gROOLIoiegq6GGF96d93u9vbCEwEuiEoIkYQHk2b_Jir2LrCXcD7xEYgf0U_C7PYPQTExvjXpbLfdzsz-Zjr9DcA6N2lgzlKJ5UOXMCFVoqizCVVMZ4o7ZyKpz8f9fPeI7R3z4znYaP6Fqfgh2oRbsIzor4OBT4zrXZOGftWTLg18TXdggeV9EVR6-_CaO2pY95GPNQicpQ2tUJ_22qE3N6M_EOZNwBp3nNFD-Nzca1Vo8q079aqrf_xG4_ifD7MID2okSjYr1XkEc7ZcguXNEqPw7zPyhsTa0Jh0X4K7VcvK2TL8jFl_4kPrQhSjKXE48VghCPdnBGN3PbUktqX2p_YcgSzx4_MvmlR1IyS2JCdtdTsJaWDCf11chiGzEzzw1qP_mxncHzDqxvGyNFEioOtbJR7D0Wjn09ZuUvd1SHTGs36iZTpwqROGysyqoZA2l4YKmeeSa-FoHhJTFrFZbmRqhowxajhHJMeNxNifZiswX45L-xSI4QMnOWobxknMugFeiyqFXgb9kki568Db5gUXuiY9D703ToqKrpkWuPJFXPkOvG5FJxXTx21Cq42WFLWxnxWhJbpgAoFQB161p9FMw7cXWdrxFGWC4wvURaIDTyrtamfJQqEx4ma82agjf5--2Ns6iAfP_l30Jdw72B4VH97tv38O9xHv1SVyqzDvT6d2DTGVVy-i7VwBRqgiUg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+trisomy+21+fibroblasts+rescue+methotrexate+toxic+effect+after+treatment+with+5%E2%80%90methyl%E2%80%90tetrahydrofolate+and+5%E2%80%90formyl%E2%80%90tetrahydrofolate&rft.jtitle=Journal+of+cellular+physiology&rft.au=Vitale%2C+Lorenza&rft.au=Serpieri%2C+Valentina&rft.au=Lauriola%2C+Mattia&rft.au=Piovesan%2C+Allison&rft.date=2019-09-01&rft.issn=0021-9541&rft.eissn=1097-4652&rft.volume=234&rft.issue=9&rft.spage=15010&rft.epage=15024&rft_id=info:doi/10.1002%2Fjcp.28140&rft.externalDBID=10.1002%252Fjcp.28140&rft.externalDocID=JCP28140 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon |